Fusion Pharmaceuticals and BWX Technologies Subsidiary Partner to Advance Cancer Treatment with Actinium225
On November 17, 2023, Fusion Pharmaceuticals and BWX Technologies subsidiary announced a groundbreaking partnership. This collaboration involves the supply of ...